| Title： | 2022 hybrid coronary revascularization experts consensus in China |
| Edition： | Updated |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Cardiologist and cardiac surgeon |
| Evidence classification method： | Evidence classification and recommendation criteria of evidence-based medicine center of Oxford University |
| Development unit： | 中国冠状动脉杂交血运重建专家共识（2022）专家组 |
| Registration time: | 2022-06-20 |
| Registration number： | IPGRP-2022CN355 |
| Purpose of the guideline: | here are no guidelines and expert consensus on coronary artery hybrid revascularization abroad. Since the publication of the Chinese expert consensus on coronary artery hybrid revascularization (2017 Edition), more and more heart centers in China have carried out hybrid revascularization surgery. With the accumulated experience of operators and / or heart teams and the development of a number of clinical trials, an expert consensus on coronary artery hybrid revascularization with Chinese characteristics has been gradually formed. Based on this, the expert group preparing this consensus, in combination with the evidence-based medicine evidence and clinical practice experience at home and abroad in recent ten years, updated the 2017 version and prepared this consensus to provide reference and basis for the promotion and standardization of hybrid revascularization of coronary heart disease in the future. |
Latest registration
